Corvus Pharmaceuticals News

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Grais Linda

Jun 17 18:51 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CLARK IAN T

Jun 17 16:51 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gould Terry P

Jun 17 16:46 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W

Jun 17 16:46 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thompson Peter A.

Jun 17 16:45 ET

Corvus Pharmaceuticals | 8-K: Current report

Jun 14 16:22 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MILLER RICHARD A MD

May 14 17:05 ET

Corvus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samlyn Capital, LLC(9.99%),Samlyn, LP(9.99%), etc.

May 13 16:55 ET

Corvus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Point72 Asset Management, L.P.(9.9%),Point72 Capital Advisors, Inc.(9.9%), etc.

May 9 17:33 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thompson Peter A.

May 8 20:35 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ORBIMED ADVISORS LLC

May 8 20:30 ET

Corvus Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(11.1%),OrbiMed Capital GP V LLC(11.1%)

May 8 20:00 ET

Corvus Pharmaceuticals | 10-Q: Quarterly report

May 7 17:22 ET

Corvus Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 7 17:21 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jones William Benton

May 7 17:11 ET

Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MILLER RICHARD A MD

May 7 17:11 ET

Corvus Pharmaceuticals | 8-K: Current report

May 6 16:17 ET

Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

May 6 16:07 ET

Corvus Pharmaceuticals | 424B5: Prospectus

May 3 16:17 ET

Corvus Pharmaceuticals | 8-K: Current report

May 1 17:12 ET